Nuveen Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $641K | Buy |
300,871
+46,632
| +18% | +$99.3K | ﹤0.01% | 2893 |
|
2024
Q3 | $712K | Buy |
254,239
+15,170
| +6% | +$42.5K | ﹤0.01% | 2891 |
|
2024
Q2 | $557K | Sell |
239,069
-63,186
| -21% | -$147K | ﹤0.01% | 2950 |
|
2024
Q1 | $1.35M | Sell |
302,255
-55,303
| -15% | -$247K | ﹤0.01% | 2575 |
|
2023
Q4 | $1.15M | Sell |
357,558
-2,643
| -0.7% | -$8.48K | ﹤0.01% | 2672 |
|
2023
Q3 | $1.14M | Buy |
360,201
+23,337
| +7% | +$74K | ﹤0.01% | 2524 |
|
2023
Q2 | $1.67M | Buy |
336,864
+63,186
| +23% | +$314K | ﹤0.01% | 2422 |
|
2023
Q1 | $1.35M | Buy |
273,678
+56,329
| +26% | +$278K | ﹤0.01% | 2493 |
|
2022
Q4 | $1.37M | Sell |
217,349
-129,820
| -37% | -$816K | ﹤0.01% | 2548 |
|
2022
Q3 | $3.75M | Sell |
347,169
-227,183
| -40% | -$2.45M | ﹤0.01% | 2060 |
|
2022
Q2 | $6.55M | Sell |
574,352
-105,469
| -16% | -$1.2M | ﹤0.01% | 1774 |
|
2022
Q1 | $6.45M | Buy |
679,821
+338,767
| +99% | +$3.22M | ﹤0.01% | 1921 |
|
2021
Q4 | $5.09M | Sell |
341,054
-104,476
| -23% | -$1.56M | ﹤0.01% | 2098 |
|
2021
Q3 | $11.5M | Sell |
445,530
-128,074
| -22% | -$3.29M | ﹤0.01% | 1686 |
|
2021
Q2 | $15M | Buy |
573,604
+345,555
| +152% | +$9.01M | ﹤0.01% | 1596 |
|
2021
Q1 | $8.05M | Sell |
228,049
-7,316
| -3% | -$258K | ﹤0.01% | 1915 |
|
2020
Q4 | $5.94M | Sell |
235,365
-118,130
| -33% | -$2.98M | ﹤0.01% | 1980 |
|
2020
Q3 | $13.3M | Sell |
353,495
-10,374
| -3% | -$391K | 0.01% | 1327 |
|
2020
Q2 | $15.6M | Buy |
363,869
+211,485
| +139% | +$9.06M | 0.01% | 1196 |
|
2020
Q1 | $2.96M | Buy |
152,384
+1,589
| +1% | +$30.9K | ﹤0.01% | 1991 |
|
2019
Q4 | $3.92M | Sell |
150,795
-422,232
| -74% | -$11M | ﹤0.01% | 2119 |
|
2019
Q3 | $15.6M | Buy |
573,027
+15,595
| +3% | +$425K | 0.01% | 1289 |
|
2019
Q2 | $15M | Buy |
+557,432
| New | +$15M | 0.01% | 1339 |
|